Nephrology and Urology Devices

miR Scientific announces commercial launch of miR Sentinel

miR Scientific has announced the commercial launch of its miR Sentinel Prostate Cancer Test in the US, Puerto Rico and…

Elypta raises funds to develop multi-cancer early detection test

Swedish diagnostics firm Elypta has raised $21m in a Series A financing round for the development of a metabolism-based multi-cancer…

Vibrant Gastro reports positive data from drug-free CIC treatment trial

Vibrant Gastro has announced positive Phase III study results of its drug-free treatment for chronic idiopathic constipation (CIC) in adult…

Quanta secures $245m to market haemodialysis system

Quanta Dialysis Technologies has raised $245m in a Series D funding round led by Glenview Capital to expedite the marketing…

Biocept and Quest Diagnostics partner on lung cancer biopsy test

Biocept has partnered with Quest Diagnostics to offer its Target Selector next-generation sequencing (NGS)-based liquid biopsy targeted lung cancer panel…

Olympus acquires Israeli medical device firm Medi-Tate 

Olympus has acquired Israeli medical device company Medi-Tate to enhance its business portfolio for in-office treatment of benign prostatic hyperplasia…

BD treats first subjects in study of WavelinQ system for fistula creation

Becton, Dickinson and Company (BD) has treated the first subjects with the WavelinQ EndoAVF System in a post-market surveillance study…

CLEP approves biomarker assays from Eurofins and Transplant Genomics

The New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) has approved two non-invasive tests from Eurofins Viracor…

Vagus nerve stimulation sheds light on tackling obesity

For most people, and to their frustration, putting on weight is much easier than shedding pounds. But obesity is not…

Medtronic drug-coated balloon shows effectiveness in lesions treatment 

Medtronic has reported that results from the study of its IN.PACT AV drug-coated balloon (DCB) showed sustained and superior effectiveness…

My Health Logic to acquire LOC technology for kidney disease diagnosis

My Health Logic, a subsidiary of Health Logic Interactive, has entered into a licence agreement with an arm’s length third…

Boston Scientific to pay US states for deceptive mesh devices marketing

Boston Scientific has agreed to pay $188.7m to settle claims made by most US states that it misled consumers on…

Boston Scientific returning to form with second major 2021 acquisition

Boston Scientific entered into a definitive agreement last week to acquire the global surgical business of Lumenis for $1.07bn in…

Boston Scientific to acquire Lumenis’ surgical business for $1.07bn

Boston Scientific has signed a definitive agreement with a Baring Private Equity Asia (BPEA) affiliate to acquire the global surgical…

FDA approves expanded MRI labeling of Medtronic’s InterStim systems

The US Food and Drug Administration (FDA) has approved expanded MRI labelling of Medtronic’s InterStim II and InterStim Micro sacral…